Can Australian Industry Deliver an A$425bn Defence Expansion?
28 August 2026.
Australia’s defence build-up tests industry, supply chains and delivery capacity
US Pharma’s Manufacturing Boom: Who Wins?
26 August 2026.
US pharma investment shifts toward strategic, complex, domestic manufacturing capacity
Washington’s $22.9bn Tomahawk Push Tests US Missile Production
21 August 2026.
Washington expands missile production, but rebuilding depleted inventories takes years
Automotive Power Electronics & Semiconductor Market to reach US$176.76 billion
19 August 2026.
Automotive Power Electronics & Semiconductor Market is valued at US$34.74 billion in 2026.
The CDMO Capacity Race Has Changed
18 August 2026.
CDMO competition shifts toward specialist capacity, geography and selective outsourcing
Clinical Trial Supply and Logistics Market for Pharma to reach US$18.22bn
18 August 2026.
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036
Macular Degeneration (AMD) & Other Retinal Diseases Drugs
17 August 2026.
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
Why Batteries, Bauxite and Magnets Are Becoming Defence Priorities
14 August 2026.
Washington targets critical material dependencies across batteries, bauxite and magnets
Can Moderna Make mRNA Work in Flu?
12 August 2026.
Moderna’s flu approval tests whether mRNA can deliver commercial scale
Washington Targets Missile and Drone Weak Links
7 August 2026.
Washington targets missile and drone bottlenecks across critical defence supply chains
Biologic Success Starts with Drug Delivery
5 August 2026.
Drug delivery is reshaping biologics development, manufacturing, access and competition
US Missile-Defence Deals Reach Deeper into the Supply Chain
31 July 2026.
Washington targets missile-supply bottlenecks to expand PAC-3 and THAAD production
Ageing Rewrites Pharma Portfolio Strategy
29 July 2026.
Ageing reshapes pharma portfolios as access, evidence and delivery determine growth
UK Raises Its Combat Air Ambitions as Canada Joins GCAP
24 July 2026.
Canada joins GCAP as Britain accelerates its next-generation combat-air strategy
Active Pharmaceutical Ingredients (APIs) Market to reach US$529.7bn
23 July 2026.
The global Active Pharmaceutical Ingredients (APIs) market is Projected to grow at a CAGR of 6.6% by 2036
When Vaccine Policy Becomes Market Risk
22 July 2026.
Policy, platforms and manufacturing are reshaping global vaccine market opportunities
Military Communications & COTS Market to Reach US$75.7bn
21 July 2026.
The global Military Communications & COTS market is projected to grow at a CAGR of 5.8% by 2036
US Defence: Faster, Lower-Cost Production
17 July 2026.
US reforms target faster production, secure supply chains, lower costs
Cell & Gene Therapy Manufacturing: The Race to Scale
15 July 2026.
Manufacturing readiness now determines which cell and gene therapies scale
GCAP’s £4.6bn: Contract Tests Military Aviation
10 July 2026.
GCAP contract tests allied ambition, industrial capacity and combat-air delivery
